Results 201 to 210 of about 211,280 (349)

Predicting Device‐Induced Platelet Damage in Assisted Circulation Using a New Biophysical Model and Experimental Validation

Artificial Organs, EarlyView.
Quantitative assessment of a newly proposed CFD‐based biophysical model for predicting device‐induced platelet damage by circulatory assist devices was performed. The new model preserved the relative trends observed previously with the power‐law formulation across a range of clinically relevant pump operating conditions, while demonstrating improved ...
Anik Tarafder, Dong Han, Bartley P. Griffith, Zhongjun J. Wu   +3 more
wiley   +1 more source

Patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic events in patients with cryptogenic stroke or transient ischemic attack and documented patent foramen ovale: a systematic review and network meta-analysis of randomized controlled trials and observational studies. [PDF]

Front Cardiovasc Med
Deng Y, An D, Xiong X, Zhou Z, Liu X, Xiang Y.   +5 more
europepmc   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Safety of Nonsteroidal Anti-Inflammatory Drug Use in Traumatic Brain Injury. [PDF]

Pharmacotherapy
Beavers J, Shultz MKC, Atchison L, Lwin C, Liu D, Chotai S, Medvecz AJ, Beyene R, Smith MC, Dennis BM, Hamblin S.   +10 more
europepmc   +1 more source

Anticoagulant Therapy in Coronary Artery Ectasia for the Prevention of Ischemic Heart Disease. [PDF]

Int J Prev Med
Safari M, Safari Z.
europepmc   +1 more source

Impact of operative time on complications after PCNL in the elderly (aged ≥70 years): the Safety and Efficacy of Nephrolithotomy in Older patients undergoing PCNL (SENIOR‐PCNL) study

BJU International, EarlyView.
Objectives To evaluate the association between operative time (OT) and postoperative complications after percutaneous nephrolithotomy (PCNL) in elderly patients, and to identify a clinically meaningful OT threshold for risk stratification. Patients and Methods A retrospective international multicentre study was performed including patients aged ≥70 ...
Łukasz Nowak, Wojciech Krajewski, Bhaskar Somani, Tomasz Szydełko, Vineet Gauhar, Steffi Kar Kei Yuen, Matthias Boeykens, Thomas Tailly, Ioannis Mykoniatis, Alba Sierra, Emre T. Sener, Vincent De Coninck, Rifat Burak Ergul, Alberto Olivero, Lazaros Tzelves, Francesco Esperto, Angelis Peteinaris, Yuigi Yuminaga, Qi Hou, Patrick Juliebø‐Jones, Arman Tsaturyan, Bartosz Małkiewicz, Agata Góral, Paulina Biesiadecka, Francisco Javier Lopez Vivo, Mantu Gupta, Juan Serna, Ziv Savin, Anastasios Anastasiadis, Dimitrios Memmos, Charlotte Slots, Rita Pages, Ceyhun Ozdemiroglu, Maria Florencia Frascheri, Rafael Carrasco Moreno, Eugenio Ventimiglia, Panagiotis Kallidonis, Evangelos Liatsikos, Otas Durutovic, Amelia Pietropaolo, Begoña Ballesta Martinez, on behalf of the YAU Working Group Endourology & Urolithiasis and the EAU Endourology Section   +41 more
wiley   +1 more source

Probabilistic Risk-Benefit Profile of Ticagrelor Monotherapy After Short Dual Antiplatelet Therapy: A Bayesian Analysis of the ULTIMATE-DAPT Trial. [PDF]

Clin Pharmacol Ther
Yang N, Xie X, Guo N, Li L, Deng N, Wang X, Yang L, Gao H.   +7 more
europepmc   +1 more source

Ischaemic stroke and 5‐fluorouracil or capecitabine: A systematic review and meta‐analysis of harms and a retrospective study of the WHO pharmacovigilance database

British Journal of Pharmacology, EarlyView.
Abstract Aim Fluoropyrimidines, including 5‐fluorouracil (5‐FU) and capecitabine, are cornerstone antineoplastic agents for cancer. Case reports suggest that these drugs may be associated with an under‐recognised risk of ischaemic stroke or transient ischaemic attack (TIA).
Sophie Nguyen, Ines Bentahrour, Camille Guerin, Charles Dolladille, Angélique Da Silva, François Cherifi, Elise‐Marie Minoc, Pierre‐Marie Morice, Nicolas Jacquin, Christophe Le Tourneau, Joachim Alexandre, Ahmad Nehme, Etienne Bastien   +12 more
wiley   +1 more source

An Uninterrupted DOAC plus Single Antiplatelet Strategy for Carotid Artery Stenting in Patients with Atrial Fibrillation. [PDF]

J Neuroendovasc Ther
Suzuki K, Horio Y, Inoue R, Wakuta N, Yamasaki N, Nii K.   +5 more
europepmc   +1 more source

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

British Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli, Cristina Madaudo, Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna   +4 more
wiley   +1 more source